Archives
-
Verteporfin Workflows for PDT and Senescence Assays
2026-08-24
Verteporfin, also known as CL 318952, supports two experimentally distinct applications: light-triggered photodynamic therapy models and light-independent studies of autophagy disruption. This guide connects those use cases with practical apoptosis, viability, senescence, and p62/LC3 workflows while emphasizing controls that prevent mechanism confusion.
-
Engineered Klotho mRNA Reverses iMSC Senescence
2026-08-23
This study shows that ARCA-capped, pseudouridine-modified Klotho mRNA delivered by hyperbranched poly(β-amino ester)s can restore Klotho expression and reduce senescence-associated dysfunction in aged and KL-deficient induced mesenchymal stem cells. Its main significance is a non-integrating, transcript-based strategy that links mRNA engineering with recovery of mitochondrial and calcium homeostasis.
-
YM-155 hydrochloride: Survivin Inhibitor Workflows
2026-08-22
Build more informative cancer drug-response experiments with YM-155 hydrochloride by separating growth inhibition from true cell killing. This workflow combines concentration control, time-resolved viability measurements, and orthogonal apoptosis readouts for stronger survivin inhibitor data across cell lines and xenograft-oriented programs.
-
L-Phenylephrine in α1A Signaling Workflows
2026-08-21
L-Phenylephrine provides a practical α1A-focused perturbation for receptor, cardiomyocyte, neural progenitor, vascular, and baroreflex studies. This guide translates sex-aware telemetry findings into reproducible assay design, dosing pilots, controls, and troubleshooting strategies.
-
Tobramycin Workflows for Resistance Research
2026-08-21
Tobramycin supports reproducible broth-based susceptibility testing, mechanism-focused microbiology, and antibiotic resistance research. This guide translates a classic comparative isolate study into practical assay design, stock preparation, quality control, and troubleshooting decisions.
-
High-Throughput BBB Permeability Model: Study Analysis
2026-08-20
Hu and colleagues developed a Transwell surrogate blood-brain barrier model that combines matched LLC-PK1-MOCK and LLC-PK1-MDR1 cells with correction for lysosomal drug trapping. Across 41 compounds, the platform connected in vitro permeability with unbound brain distribution and improved interpretation of compounds whose low recovery would otherwise obscure their permeability.
-
Machine Learning for Senolytic Discovery
2026-08-20
The Nature Communications study developed a cost-effective machine-learning workflow that used published screening data to identify new senolytic candidates. Computational screening followed by validation in human cell models identified ginkgetin, periplocin, and oleandrin, demonstrating how small, heterogeneous datasets can support early-stage drug discovery.
-
T. pallidum Drives ROS-Linked Hepatocyte Apoptosis
2026-08-19
A 2026 study in Microbial Pathogenesis identifies mitochondrial reactive oxygen species accumulation and cardiolipin peroxidation as central events linking Treponema pallidum exposure to intrinsic apoptosis in hepatocytes. Its combined analysis of ATP depletion, membrane-potential loss, mitochondrial permeability, oxidative stress, cardiolipin oxidation, and apoptotic signaling provides a mechanistic framework for investigating syphilis-associated liver injury.
-
Sex Differences in Ang II Hypertension in Mice
2026-08-19
Xue, Pamidimukkala, and Hay used telemetry in conscious, freely moving mice to show that chronic angiotensin II produces a substantially larger pressor response in males than females. Gonadectomy, baroreflex testing, and ganglionic blockade further linked this divergence to sex-dependent hormone effects, reflex control, and sympathetic support of blood pressure.
-
Mitochondrial Permeability Transition Pore Assay Kit Guide
2026-08-18
Turn mitochondrial pore opening into a measurable fluorescence signal with a workflow built for infection, apoptosis, and mitochondrial dysfunction models. This guide combines Calcein AM imaging, cobalt quenching, practical controls, and troubleshooting for more defensible cell death mechanism research.
-
From Astrocyte Atlas to Spatial Proof
2026-08-18
Transcriptomic atlases reveal where astrocyte identities diverge, but spatial assays determine whether those molecular signatures resolve in preserved cells and tissue. This thought-leadership article explains how tyramide signal amplification can help translational researchers validate atlas-derived candidates, compare developmental and regional biology, and design more defensible fluorescence workflows.
-
TG003 Cdc2-like Kinase Inhibitor Workflow
2026-08-17
TG003 is a practical probe for connecting Clk-dependent phosphorylation with alternative splicing, DNA-damage responses, and platinum resistance. This workflow explains how to use its kinase selectivity profile, controls, and orthogonal readouts without mistaking a pan-Clk effect for a CLK2-specific mechanism.
-
Photodynamic Therapy and STING Activation in Breast Cancer
2026-08-17
The reference study developed GM@P nanoparticles that combine MHI148-targeted photodynamic therapy with delivery of 2'3'-cGAMP to activate STING. This integrated design linked tumor-cell ablation, immunogenic cell death, type I interferon induction, and improved antitumor immune-cell recruitment, providing a mechanistic strategy for limiting breast cancer metastasis and recurrence.
-
EphA2 Synthetic Lethality in MYC-Driven TNBC
2026-08-16
A recent Experimental Cell Research study used a chemogenetic kinase-inhibitor screen to identify EphA2 as a synthetic lethal vulnerability in MYC-driven triple-negative breast cancer. The EphA2 inhibitor ALW-II-41-27 selectively induced intrinsic apoptosis, retained activity across p53 backgrounds, and reduced tumor growth in two TNBC xenograft models, while also highlighting the need for deeper genetic and pharmacological validation.
-
Annexin V-PE Apoptosis Detection Kit Workflows
2026-08-15
Build faster live-cell death assays around phosphatidylserine externalization, with practical workflows for flow cytometry and fluorescence microscopy. The approach extends inflammatory monocyte studies by separating cytokine suppression from treatment-related loss of cell integrity.